Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001553350-15-001055
Filing Date
2015-10-08
Accepted
2015-10-08 16:51:50
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT mdst_10k.htm 10-K/A 693959
2 CONSENT OF AUDITORS mdst_ex23z1.htm EX-23.1 2545
3 OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT mdst_ex31z1.htm EX-31.1 5459
4 OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT mdst_ex31z2.htm EX-31.2 5575
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED mdst_ex32z1.htm EX-32.1 2557
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED mdst_ex32z2.htm EX-32.2 2550
7 GRAPHIC mdst_10k002.gif GRAPHIC 8492
8 GRAPHIC mdst_10k004.gif GRAPHIC 6726
9 GRAPHIC mdst_ex23z1002.gif GRAPHIC 8492
10 GRAPHIC mdst_ex23z1003.jpg GRAPHIC 3271
  Complete submission text file 0001553350-15-001055.txt   3232918

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE mdst-20141231.xml EX-101.INS 521447
12 XBRL SCHEMA FILE mdst-20141231.xsd EX-101.SCH 35961
13 XBRL CALCULATION FILE mdst-20141231_cal.xml EX-101.CAL 43965
14 XBRL DEFINITION FILE mdst-20141231_def.xml EX-101.DEF 98316
15 XBRL LABEL FILE mdst-20141231_lab.xml EX-101.LAB 263937
16 XBRL PRESENTATION FILE mdst-20141231_pre.xml EX-101.PRE 208809
Mailing Address 429 KENT STREET UNIT 112 OTTAWA A6 K2P 2B4
Business Address 429 KENT STREET UNIT 112 OTTAWA A6 K2P 2B4 613 241-9969
CTT PHARMACEUTICAL HOLDINGS, INC. (Filer) CIK: 0001035422 (see all company filings)

EIN.: 113763974 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30651 | Film No.: 151151233
SIC: 1040 Gold and Silver Ores